Praxis Precision Medicines, Inc. (PRAX)
NASDAQ: PRAX · Real-Time Price · USD
34.75
-3.31 (-8.58%)
Mar 3, 2025, 3:05 PM EST - Market open
PRAX Stock Forecast
Stock Price Forecast
The 10 analysts with 12-month price forecasts for PRAX stock have an average target of 123.8, with a low estimate of 48 and a high estimate of 270. The average target predicts an increase of 256.26% from the current stock price of 34.75.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for PRAX stock from 10 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
---|---|---|---|---|---|---|
Strong Buy | 5 | 5 | 5 | 5 | 6 | 6 |
Buy | 3 | 3 | 3 | 3 | 3 | 3 |
Hold | 1 | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 9 | 9 | 9 | 9 | 10 | 10 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Truist Securities | Truist Securities | Strong Buy Maintains $175 → $85 | Strong Buy | Maintains | $175 → $85 | +144.60% | Mar 3, 2025 |
Baird | Baird | Buy Maintains $117 → $73 | Buy | Maintains | $117 → $73 | +110.07% | Mar 3, 2025 |
Needham | Needham | Strong Buy Maintains $150 → $85 | Strong Buy | Maintains | $150 → $85 | +144.60% | Mar 3, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $120 → $105 | Strong Buy | Maintains | $120 → $105 | +202.16% | Mar 3, 2025 |
Deutsche Bank | Deutsche Bank | Strong Buy Initiates $111 | Strong Buy | Initiates | $111 | +219.42% | Feb 11, 2025 |
Financial Forecast
Revenue This Year
1.01M
from 8.55M
Decreased by -88.20%
Revenue Next Year
34.40M
from 1.01M
Increased by 3,309.71%
EPS This Year
-11.93
from -10.21
EPS Next Year
-12.00
from -11.93
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 3.2M | 77.0M | 201.8M | ||
Avg | 1.0M | 34.4M | 109.5M | ||
Low | n/a | 844,760 | 29.1M |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | -63.2% | 7,527.8% | 486.6% | ||
Avg | -88.2% | 3,309.7% | 218.2% | ||
Low | - | -16.3% | -15.4% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | -9.93 | -9.39 | -2.94 | ||
Avg | -11.93 | -12.00 | -9.89 | ||
Low | -14.57 | -18.94 | -15.47 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.